Ricky Williams & Josh Gordon: NFL Cannabis Suspensions That Drove Reform

Ricky Williams: The Pre-CBA Template

Few NFL careers were more directly shaped by cannabis policy than Ricky Williams's. Williams missed the 2004 and 2006 NFL seasons following multiple suspensions under the pre-2020 NFL Substance Abuse Policy — the framework that operated at a 15 ng/mL THC-COOH threshold until 2014 and 35 ng/mL from 2014 to 2020. The Williams suspensions were among the highest-profile, multi-season disciplinary outcomes the policy produced.

Williams's post-career trajectory is now part of the case record cited in CBA negotiations. He founded Real Wellness in 2018 and the lifestyle brand Highsman in 2021 — two of the most named NFL-alumni cannabis ventures, alongside Calvin Johnson and Rob Sims's Primitiv Group, Marshawn Lynch's Dodi Blunts, Marvin Washington's Athletes for CARE work, and Kyle Turley's Neuro XPF.

Josh Gordon: The Most-Cited Career-Halting Case

Josh Gordon's repeated multi-year suspensions during 2014–2019 effectively halted his prime. Gordon's case is the most-cited individual case in the 2020 NFL-NFLPA CBA negotiations that ended suspensions for positive cannabis tests — the principle that an elite wide receiver could see consecutive years of his prime erased by a substance with no demonstrated performance-enhancing effect (see THC and Performance) was the through-line argument his case made for reform.

The March 2020 NFL-NFLPA CBA

The March 2020 NFL-NFLPA collective-bargaining agreement — ratified directly in the Williams/Gordon shadow — produced four structural changes to the league's cannabis policy:

• Suspensions ended. Positive cannabis tests no longer trigger game-action discipline.
• Threshold raised. The urinary THC-COOH threshold rose from 35 ng/mL to 150 ng/mL, aligning with WADA's post-2013 standard.
• Testing window narrowed. Cannabis testing shrank to roughly the two-week window from start of training camp to first preseason game; out-of-camp use stopped triggering tests entirely.
• Joint Pain Management Committee. The CBA created the PMC co-chaired by Dr. Kevin Hill (Beth Israel Deaconess; Harvard Medical School) and Dr. Thom Mayer for the NFLPA — the body that subsequently funded NFL cannabis pain research at UC San Diego, the University of Regina, ASPN, and Emory.

The December 6, 2024 Modification

The December 6, 2024 NFL-NFLPA modification — first reported by ESPN's Adam Schefter and the Associated Press — raised the THC threshold from 150 to 350 ng/mL, the highest of any major U.S. sports body, and replaced game-check fines with fixed-dollar fines: $15,000 for a first offense and $20,000 for a second. The shift from variable game-check loss to fixed dollar fines decoupled the financial penalty from player salary, removing the disproportionate impact on lower-paid players that the prior scheme produced.

The Modern Active-Player Caseload

Under the post-2024 framework, the active-player caseload is dramatically smaller than the Williams/Gordon era. Reported THC fines and cases involving DeAndre Hopkins, Marquise "Hollywood" Brown, Ja'Marr Chase, and a discrimination lawsuit by ex-Broncos lineman Eyioma Uwazurike (filed 2024) over fines tied to a synthetic-cannabinoid prescription illustrate that the policy is evolving but not eliminated. The contrast with Williams missing 2004 and 2006 entirely is the measure of how far the league has moved.

Why These Two Cases Matter

The Williams/Gordon throughline carried the argument that the punishment-to-evidence ratio of the pre-2020 NFL policy could not survive contact with collective-bargaining scrutiny. Williams supplied the multi-season-suspension precedent; Gordon supplied the prime-years-erased precedent. Together they made the case that ended NFL cannabis suspensions and seeded the more recent Eugene Monroe and Calvin Johnson reform-and-research-and-business throughline. For the broader NFL alumni cannabis-business ecosystem they helped legitimise, see Athlete-Founded Brands.